Apyx Medical Corp (APYX) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30..
Borrowing debt
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 35.33M USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 61.07M USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | (m) | $35.33M | (m) | (m) | $61.07M | (m) |
| 2026-03-31 | (m) | (m) | (m) | $35.09M | (m) | (m) | $63.02M | (m) |
| 2025-12-31 | (m) | (m) | (m) | $34.85M | (m) | (m) | $66.84M | (m) |
| 2025-09-30 | (m) | (m) | (m) | $34.61M | (m) | (m) | $57.37M | (m) |
| 2025-06-30 | (m) | (m) | (m) | $34.37M | (m) | (m) | $58.19M | (m) |
| 2025-03-31 | (m) | (m) | (m) | $34.13M | (m) | (m) | $60.16M | (m) |
| 2024-12-31 | (m) | (m) | (m) | $33.89M | (m) | (m) | $64.84M | (m) |
| 2024-09-30 | (m) | (m) | (m) | $33.85M | (m) | (m) | $60.72M | (m) |
| 2024-06-30 | (m) | (m) | (m) | $33.63M | (m) | (m) | $65.39M | (m) |
| 2024-03-31 | (m) | (m) | (m) | $33.41M | (m) | (m) | $70.71M | (m) |
| 2023-12-31 | (m) | (m) | (m) | $33.19M | (m) | (m) | $79.24M | (m) |
| 2023-09-30 | (m) | (m) | (m) | $9.01M | (m) | (m) | $59.45M | (m) |
| 2023-06-30 | (m) | (m) | $8.89M | (m) | (m) | (m) | $62.43M | (m) |
| 2023-03-31 | (m) | (m) | $8.78M | (m) | (m) | (m) | $56.78M | (m) |
| 2022-12-31 | (m) | (m) | $0.00 | (m) | (m) | (m) | $51.77M | (m) |
| 2018-12-31 | (m) | (m) | $0.00 | $0.00 | (m) | (m) | $95.61M | (m) |
| 2018-09-30 | (m) | (m) | $0.00 | $0.00 | (m) | (m) | $113.11M | (m) |
| 2018-06-30 | (m) | (m) | $239.00K | $2.33M | (m) | (m) | $30.65M | (m) |
| 2018-03-31 | (m) | (m) | $239.00K | $2.40M | (m) | (m) | $30.11M | (m) |
| 2017-12-31 | (m) | (m) | $239.00K | $2.46M | (m) | (m) | $30.99M | (m) |
| 2017-09-30 | (m) | (m) | $239.00K | $2.52M | (m) | (m) | $30.70M | (m) |
| 2017-06-30 | (m) | (m) | $239.00K | $2.58M | (m) | (m) | $32.56M | (m) |
| 2017-03-31 | (m) | (m) | $239.00K | $2.63M | (m) | (m) | $33.09M | (m) |
| 2016-12-31 | (m) | (m) | $239.00K | $2.69M | (m) | (m) | $35.11M | (m) |
| 2015-12-31 | (m) | (m) | $239.00K | $2.93M | (m) | (m) | $31.45M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |